UPDATE : Thursday, December 12, 2019
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022 by Nam Doo-hyun 2017-11-17 13:53
Earthquake hits biopharmaceutical factories in Pohang by Nam Doo-hyun 2017-11-16 15:55
J&J struggles to maintain market dominance of Remicade by Lee Han-soo and Nam Doo-hyun 2017-11-16 10:25
Hugel merges with subsidiaries by Lee Han-soo 2017-11-15 17:51
Macrogen reaffirms diagnostic sequencing capability with CAP certification by Constance Williams 2017-11-15 14:48
Janssen drops suit against Samsung Bioepis on Renflexis by Lee Han-soo 2017-11-14 17:59
Celltrion to test combo therapy of new flu antibody drug, Tamiflu by Lee Hye-seon 2017-11-14 11:38
Biopharmaceutical firms rank high in Kosdaq market cap by Nam Doo-hyun 2017-11-13 15:25
KIST to transfer immune-enhancing tech to EuBiologics by Constance Williams 2017-11-13 12:14
Samsung Bioepis gets sales license for Samfenet by Lee Han-soo 2017-11-09 16:03
GemVax & KAEL place 1st in patent competition by Marian Chu 2017-11-09 14:26
Medipost’s CellTree emerges as nation’s leading cord blood bank by Marian Chu 2017-11-09 11:32
Toolgen registers ‘reporter gene’ patent for US genome editing by Constance Williams 2017-11-08 16:36
Medipost gets Chinese patent for next-generation stem cell technology by Constance Williams 2017-11-08 15:12
World’s 1st gene therapy for osteoarthritis administered in Korea by Marian Chu 2017-11-08 12:52
ViroMed, Reyon in legal battle over gene therapy patent rights by Nam Doo-hyun 2017-11-07 14:10
TissueGene shares trade low in Kosdaq debut by So Jae-hyeon 2017-11-06 15:47
Celltrion, Baxter BioPharma signs CMO accord for biosimilar production by Constance Williams 2017-11-03 11:44
Samsung BioLogics, Merck to extend strategic alliance by Lee Han-soo 2017-11-02 11:20
Celltrion’s US sales of Remsima up 48% in Q3 by Nam Doo-hyun 2017-11-01 15:51
Back to Top